Science

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

David Sher/utsouthwestern.edu

Apr 21, 2025, 08:59

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

ASTRO shared a post on X:

“Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study by David Sher, et al.

Read about it in the Red Journal.”

David Sher, Medical Director of Radiation Oncology, Chief of Head and Neck Radiation Oncology Service, reshared the post on X, adding:

“In this paper, we analyzed the UTSW Radiation Oncology experience with adapt-on-demand for H&N squamous cell carcinoma using the Varian Ethos system.

TL/DR: Significant (and I think meaningful) improvement in coverage and homogeneity, but no clinically impactful reduction in OAR doses.”

Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study.

Authors: Julia J. Shi, et al.

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

ASTRO cancer David Sher Dosimetric fight against cancer Global fight against cancer head and neck squamous cell carcinoma Neck Radiation Oncology OncoDaily Oncology radiation oncology radiation therapy Red Journal squamous cell carcinoma UTSW Radiation Oncology

Marking One Year of Progress in IDH-Mutant Glioma Treatment - Servier Pharmaceuticals

James Whale Dies at 74: The Radio Icon’s Long Fight Against Kidney Cancer

A Pivotal Day for Geron

Top GU Immunotherapy Trials to Watch at ESMO 2025

Julie Gralow Received the 2025 NCG Lifetime Achievement Award in Oncology